Psoriasis Drugs Market Size, Share & Trends Report

Psoriasis Drugs Market (2025 - 2030) Size, Share & Trends Analysis Report By Class, By Treatment (Topicals, Systemic, Biologics), By Route Of Administration (Oral, Parenteral), By Distribution Channel, By Region, And Segment Forecasts

Market Segmentation

Psoriasis Drug Class Outlook (Revenue, USD Million, 2018 - 2030)
- Tumor Necrosis Factor Inhibitors
- Interleukin Inhibitors
- Vitamin D Analogues
- Corticosteroids
- Others
Psoriasis Drug Treatment Outlook (Revenue, USD Million, 2018 - 2030)
- Topicals
- Systemic
- Biologics
Psoriasis Drug Route of Administration Outlook (Revenue, USD Million, 2018 - 2030)
- Oral
- Parenteral
- Topical
Psoriasis Drug Distribution Channel Outlook (Revenue, USD Million, 2018 - 2030)
- Hospital Pharmacies
- Retail Pharmacies
- Others
Psoriasis Drug Regional Outlook (Revenue, USD Million, 2018 - 2030)
- North America
  - North America Psoriasis Drug Market, by Class
    - Tumor Necrosis Factor Inhibitors
    - Interleukin Inhibitors
    - Vitamin D Analogues
    - Corticosteroids
    - Others
  - North America Psoriasis Drug Market, by Treatment
    - Topicals
    - Systemic
    - Biologics
  - North America Psoriasis Drug Market, by Route of Administration
    - Oral
    - Parenteral
    - Topical
  - North America Psoriasis Drug Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - U.S.
    - U.S. Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - U.S. Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - U.S. Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - U.S. Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Canada
    - Canada Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Canada Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Canada Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Canada Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Mexico
    - Mexico Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Mexico Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Mexico Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Mexico Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Europe
  - Europe Psoriasis Drug Market, by Class
    - Tumor Necrosis Factor Inhibitors
    - Interleukin Inhibitors
    - Vitamin D Analogues
    - Corticosteroids
    - Others
  - Europe Psoriasis Drug Market, by Treatment
    - Topicals
    - Systemic
    - Biologics
  - Europe Psoriasis Drug Market, by Route of Administration
    - Oral
    - Parenteral
    - Topical
  - Europe Psoriasis Drug Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - UK
    - UK Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - UK Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - UK Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - UK Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Germany
    - Germany Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Germany Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Germany Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Germany Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - France
    - France Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - France Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - France Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - France Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Italy
    - Italy Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Italy Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Italy Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Italy Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Spain
    - Spain Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Spain Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Spain Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Spain Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Denmark
    - Denmark Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Denmark Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Denmark Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Denmark Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Sweden
    - Sweden Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Sweden Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Sweden Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Sweden Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Norway
    - Norway Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Norway Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Norway Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Norway Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Asia Pacific
  - Asia Pacific Psoriasis Drug Market, by Class
    - Tumor Necrosis Factor Inhibitors
    - Interleukin Inhibitors
    - Vitamin D Analogues
    - Corticosteroids
    - Others
  - Asia Pacific Psoriasis Drug Market, by Treatment
    - Topicals
    - Systemic
    - Biologics
  - Asia Pacific Psoriasis Drug Market, by Route of Administration
    - Oral
    - Parenteral
    - Topical
  - Asia Pacific Psoriasis Drug Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Japan
    - Japan Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Japan Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Japan Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Japan Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - China
    - China Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - China Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - China Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - China Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - India
    - India Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - India Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - India Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - India Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Australia
    - Australia Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Australia Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Australia Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Australia Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - South Korea
    - South Korea Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - South Korea Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - South Korea Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - South Korea Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Thailand
    - Thailand Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Thailand Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Thailand Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Thailand Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Latin America
  - Latin America Psoriasis Drug Market, by Class
    - Tumor Necrosis Factor Inhibitors
    - Interleukin Inhibitors
    - Vitamin D Analogues
    - Corticosteroids
    - Others
  - Latin America Psoriasis Drug Market, by Treatment
    - Topicals
    - Systemic
    - Biologics
  - Latin America Psoriasis Drug Market, by Route of Administration
    - Oral
    - Parenteral
    - Topical
  - Latin America Psoriasis Drug Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - Brazil
    - Brazil Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Brazil Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Brazil Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Brazil Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Argentina
    - Argentina Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Argentina Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Argentina Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Argentina Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
- Middle East & Africa
  - Middle East & Africa Psoriasis Drug Market, by Class
    - Tumor Necrosis Factor Inhibitors
    - Interleukin Inhibitors
    - Vitamin D Analogues
    - Corticosteroids
    - Others
  - Middle East & Africa Psoriasis Drug Market, by Treatment
    - Topicals
    - Systemic
    - Biologics
  - Middle East & Africa Psoriasis Drug Market, by Route of Administration
    - Oral
    - Parenteral
    - Topical
  - Middle East & Africa Psoriasis Drug Market, by Distribution Channel
    - Hospital Pharmacies
    - Retail Pharmacies
    - Others
  - South Africa
    - South Africa Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - South Africa Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - South Africa Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - South Africa Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Saudi Arabia
    - Saudi Arabia Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Saudi Arabia Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Saudi Arabia Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Saudi Arabia Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - UAE
    - UAE Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - UAE Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - UAE Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - UAE Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others
  - Kuwait
    - Kuwait Psoriasis Drug Market, by Class
      - Tumor Necrosis Factor Inhibitors
      - Interleukin Inhibitors
      - Vitamin D Analogues
      - Corticosteroids
      - Others
    - Kuwait Psoriasis Drug Market, by Treatment
      - Topicals
      - Systemic
      - Biologics
    - Kuwait Psoriasis Drug Market, by Route of Administration
      - Oral
      - Parenteral
      - Topical
    - Kuwait Psoriasis Drug Market, by Distribution Channel
      - Hospital Pharmacies
      - Retail Pharmacies
      - Others

Report content

Qualitative Analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments